JP Morgan Chase
TECH icon

JP Morgan Chase’s Bio-Techne TECH Stock Holding History

JP Morgan Chase’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-130,000
Closed -$9.31M – 7672
2024
Q2 		$9.31M Buy
+130,000
New +$9.57M ﹤0.01% 2524

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase's TECH Position: Q1 2026 in Review

JP Morgan Chase increased its Bio-Techne (TECH) stake by 35% in Q1 2026, buying an estimated $16M and bringing the position to 1,025,105 shares worth $53.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1362.

JP Morgan Chase first reported a position in TECH in Q2 2013 and has held it in 51 quarters since. The position peaked at $105M in Q3 2021. 584 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • JP Morgan Chase held 1,025,105 shares of Bio-Techne worth $53.3M as of Q1 2026.
  • JP Morgan Chase bought 266,023 Bio-Techne shares in Q1 2026, an estimated $16M.
  • Bio-Techne made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1362 holding.
  • JP Morgan Chase first reported a position in Bio-Techne in Q2 2013 and has held it in 51 quarters since.
  • JP Morgan Chase's Bio-Techne position peaked at $105M in Q3 2021.
  • 584 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.